Molbio Diagnostics

1,423.40

-18.90

(-1.31%)

Market Cap

16,403.26 Cr

PE Ratio

101.34

Volume

2,15,067.00

Day High - Low

1,455.70 - 1,407.10

52W High-Low

1,686.80 - 807.00

compare with

No Peers Availabel for Comparision

Key Fundamentals

Market Cap

16,403.26 Cr

EPS

14.77

PE Ratio

101.34

PB Ratio

12.14

Book Value

118.84

EBITDA

330.90

Dividend Yield

0.00 %

Industry

Sector

Return on Equity

12.54

Debt to Equity

0.28

Actual

Company News

View All News

Kotak MF crosses 5% stake in Molbio Diagnostics

Today

Kotak Mahindra Mutual Fund acquired 570,000 shares of Molbio Diagnostics, pushing its holding to 5.4834% under SAST regulations.

Molbio Diagnostics sees 2.06% stake sell-off

Oct 01, 2026

India Business Excellence Fund III sold 23,77,627 shares of Molbio Diagnostics, reducing its holding to 6.85%.

Molbio Diagnostics shares flag large trade on BSESep 30, 2026

A large-trade signal flagged approximately 22,32,574 Molbio Diagnostics shares changing hands on BSE at ₹1,315.00, with a combined value of ₹305.42 crore.

Growth Rate

Revenue Growth

41.57 %

Net Income Growth

18.40 %

Cash Flow Change

-82.45 %

ROE

-12.49 %

ROCE

-20.01 %

EBITDA Margin (Avg.)

-13.34 %

Corporate Action

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
05 Sept 2026	Quarterly Result Announcement	NA	05 Sept 2026	1,086.30	1,160.50

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
ICICI Prudential Quality Fund Direct-Growth	0.66%	100886	0.66%	0.66%
WhiteOak Capital Aggressive Hybrid Fund Direct-Growth	0.93%	-1815	0.03%	0.93%
Kotak Mid Cap Fund Direct-Growth	0.54%	0	0.00%	0.54%
Nippon India Innovation Fund Direct-Growth	0.73%	0	0.00%	0.13%
HDFC MNC Fund Direct-Growth	0.97%	0	0.00%	-0.54%
HDFC Pharma And Healthcare Fund Direct-Growth	2.01%	0	0.00%	0.24%
HDFC Value Fund Direct Plan-Growth	0.54%	0	0.00%	0.10%
ICICI Prudential Exports and Services Fund Direct-Growth	1.03%	0	0.00%	-0.01%
HDFC Flexi Cap Direct Plan-Growth	0.28%	0	0.00%	0.28%
Kotak Aggressive Hybrid Fund Direct-Growth	2.17%	0	0.00%	0.78%
Kotak Conservative Hybrid Fund Direct-Growth	0.35%	0	0.00%	0.18%
Kotak Consumption Fund Direct-Growth	1.14%	0	0.00%	0.23%
Kotak Contra Fund Direct-Growth	1.31%	0	0.00%	0.29%
Kotak Focused Fund Direct-Growth	0.18%	0	0.00%	0.18%
Kotak Healthcare Fund Direct-Growth	5.08%	0	0.00%	0.55%
Kotak Large Cap Fund Direct-Growth	0.43%	0	0.00%	0.13%
HDFC Innovation Fund Direct-Growth	0.45%	0	0.08%	0.45%
Edelweiss Equity Savings Fund Direct-Growth	0.71%	0	0.00%	0.11%
PGIM India Healthcare Fund Direct-Growth	0.80%	0	0.00%	0.80%
Mirae Asset Healthcare Fund Direct-Growth	1.77%	0	0.00%	0.33%
Mirae Asset Small Cap Fund Direct-Growth	0.55%	0	0.00%	0.25%
Motilal Oswal Large Cap Fund Direct-Growth	0.28%	0	0.00%	-0.15%
Kotak Multi Asset Allocation Fund Direct-Growth	0.03%	0	0.00%	0.01%
Nippon India Pharma Fund Direct-Growth	0.54%	0	0.00%	0.10%
Mirae Asset Flexi Cap Fund Direct-Growth	1.05%	0	0.00%	0.03%

Technical Indicators

RSI(14)

Neutral

59.48

ATR(14)

Less Volatile

100.23

STOCH(9,6)

Neutral

75.49

STOCH RSI(14)

Neutral

48.23

MACD(12,26)

Bullish

17.01

ADX(14)

Strong Trend

38.24

Bearish

52.66

ROC

Uptrend And Accelerating

9.83

WillR

Neutral

-38.09

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Molbio Diagnostics

Company News

Corporate Action

Mutual Fund Holdings

Technical Indicators